What is the share price of Classic Biotech & Exports Ltd (531670)?

Company share prices are keep on changing according to the market conditions. The current trading price of Classic Biotech & Exports Ltd (531670) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Classic Biotech & Exports?

The latest standalone P/E ratio of Classic Biotech & Exports as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Classic Biotech & Exports Ltd (531670)?

The latest standalone P/B ratio of Classic Biotech & Exports Ltd (531670) as of 01-Jan-1970 is 1.89.

What is the 52-week high and low of Classic Biotech & Exports Ltd (531670)?

The 52-week high of Classic Biotech & Exports Ltd (531670) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Classic Biotech & Exports Ltd (531670) Share Analysis – Quality, Growth & Valuation Zone & DeciZen Rating

Name: Classic Biotech & Exports Ltd (531670)
Brand: Classic Biotech & Exports

Classic Biotech & Exports Ltd (531670) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating

Key Metrics

Market Cap

₹3 Cr.

P/E Ratio

0.00

Price to Book (P/B)

1.89

Price to Sales (P/S)

4.43

EV/EBITDA

-78.92

Return on Capital Employed (ROCE)

-7.63%

Current Price

₹0

Return on Equity (ROE)

-36.56%

Return on Assets (ROA)

-7.35%

Operating Profit Margin

-13.4%

Net Profit Margin

-57.23%

Gross Profit Margin

-13.2%

Book Value per Share

₹3.3

Sales Growth (YoY)

-22.22%

Sales Growth (3 Years)

-11.21%

Operating Profit Growth (1 Year)

NA%

Operating Profit Growth (3 Years)

N/A%

Net Profit Growth (1 Year)

NA%

52-Week Low / High

₹0 / 0

Net Profit Growth (3 Years)

N/A%

Dividend Yield

0.00%

Promoter Holding

8.30%

Pledged shares (%)
of Promoter's holding (%)

0.00%

DeciZen - make an informed investing decision on Classic Biotech

Based on:

Data

M-Cap below 100cr DeciZen not available

Classic Biotech & Exports stock performance

Key Ratios

Is an attractive stock to invest in?

1. Is a good quality company?

Data is not available for this company.

2. Is undervalued or overvalued?

No data found

3. Is a good buy now?

No data found

10 Year X-Ray :

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	TTM
ROCE % ⓘ	9.3%	3.2%	-1%	-8.8%	-11.4%	-7.9%	-11.8%	-10.6%	-11.1%	-7.6%	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	1.8	1.6	1.6	1.1	0.8	1.1	1	1	0.9	0.7	1
Sales YoY Gr.	-	-9.5%	-2.5%	-33.5%	-21%	32.5%	-9.1%	-4%	-6.3%	-22.2%	-
Adj EPS ⓘ	0.9	-0	-0.2	-1.3	-1.6	-1	-1.4	-1.2	-1.2	-0.8	-0.8
YoY Gr.	-	-103.3%	NA	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	8.3	7.9	7.6	6	4.5	4.1	3.7	3.3	2.6	1.8	3.3
Adj Net Profit ⓘ	0.5	-0	-0.1	-0.7	-0.8	-0.5	-0.7	-0.6	-0.6	-0.4	-0
Cash Flow from Ops. ⓘ	0.8	0.1	-0.4	-0.2	-0.4	0	0	0	0	-0.1	-
Debt/CF from Ops. ⓘ	5	78.7	-12.3	-18.2	-10.2	564.3	146.7	168.6	106.9	-86.2	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-9.9%	-3.4%	-11.2%	-22.2%
Adj EPS ⓘ	-198.5%	NA	NA	NA
BVPSⓘ	-15.6%	-16.7%	-21.5%	-30.8%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09	TTM
Return on Equity % ⓘ	12	-0.4	-1.9	-13.9	-18.9	-14.2	-24.7	-28	-38.7	-36.6	-31.5
Op. Profit Mgn % ⓘ	44.3	23.1	9.2	-33.9	-55.9	-15.7	-39	-31.7	-34.9	-13.4	-18.5
Net Profit Mgn % ⓘ	25.8	-1	-5.8	-64.3	-94	-45.7	-71.9	-64.9	-69.6	-57.2	-57.6
Debt to Equity ⓘ	1.1	1.3	1.1	1.4	1.9	2.1	2.2	2.6	3.2	4.6	-
Working Cap Days ⓘ	67	71	93	144	130	105	149	194	218	268	0
Cash Conv. Cycle ⓘ	-28	-7	31	67	28	17	64	106	121	126	0

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to %

Sales growth has been subdued in last 3 years %

Sales growth is not so good in last 4 quarters at %

Latest Financials

	Standalone	Consolidated
TTM EPS (₹)	-0.8	-
TTM Sales (₹ Cr.)	0.7	-
BVPS (₹) ⓘ	3.3	-
Reserves (₹ Cr.) ⓘ	-3	-
P/BV ⓘ	1.89	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	0.00 / 0.00
All Time Low / High (₹)	1.50 / 61.85
Market Cap (₹ Cr.)	3.1
Equity (₹ Cr.)	5
Face Value (₹)	10
Industry PE ⓘ	19.3

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Classic Biotech - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Key Ratios

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Sales	1.79	1.62	1.58	1.05	0.83	1.10	1	0.96	0.90	0.70
Operating Expenses ⓘ +	1.07	1.25	1.44	1.41	1.30	1.27	1.39	1.27	1.21	0.80
Manufacturing Costs	0.06	0.13	0.17	0.20	0.12	0.13	0.07	0.08	0.08	0.12
Material Costs	0.48	0.52	0.55	0.42	0.35	0.37	0.47	0.51	0.57	0.40
Employee Cost	0.04	0.06	0.10	0.09	0.07	0.08	0.17	0.14	0.18	0.17
Other Costs ⓘ	0.48	0.54	0.62	0.70	0.75	0.69	0.69	0.53	0.39	0.10
Operating Profit ⓘ	0.72	0.37	0.15	-0.36	-0.47	-0.17	-0.39	-0.31	-0.31	-0.09
Operating Profit Margin (%)	40.4%	22.9%	9.2%	-33.9%	-55.9%	-15.7%	-38.9%	-31.7%	-34.9%	-13.4%
Other Income ⓘ +	0.02	0	0.01	0	0	0	0	0	0	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0.19	0.26	0.01	0	0	0	0	0	0	0
Depreciation ⓘ	0.12	0.13	0.23	0.32	0.32	0.33	0.33	0.32	0.31	0.31
Profit Before Tax ⓘ	0.42	-0.02	-0.09	-0.67	-0.78	-0.50	-0.72	-0.62	-0.62	-0.40
Tax ⓘ	0.01	0	0	0	0	0	0	0	0	0
Profit After Tax	0.42	-0.02	-0.09	-0.67	-0.78	-0.50	-0.72	-0.63	-0.62	-0.40
PAT Margin (%)	23.2%	-1.2%	-5.5%	-64.3%	-94.0%	-45.7%	-71.9%	-64.9%	-69.6%	-57.2%
Adjusted EPS (₹)	1.0	-0.0	-0.2	-1.4	-1.6	-1.0	-1.4	-1.3	-1.3	-0.8
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Equity and Liabilities
Shareholders Fund +	4.21	4.55	5.20	4.53	3.77	3.27	2.55	1.93	1.30	0.90
Share Capital ⓘ	4.06	4.25	4.97	4.97	5	5	5	5	5	5
Reserves ⓘ	0.15	0.30	0.23	-0.45	-1.23	-1.73	-2.45	-3.07	-3.70	-4.10
Debt +	3.84	4.30	4.27	4.27	4.15	4.15	4.15	4.15	4.15	4.15
Long Term Debt	3.84	4.30	4.27	4.27	4.15	4.15	4.15	4.15	4.15	4.15
Short Term Debt	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.11	0.13	0.08	0.14	0.13	0.11	0.10	0.14	0.14	0.19
Others Liabilities ⓘ	0.04	0.04	0.04	0.04	0.07	0.05	0.05	0.05	0.05	0.05
Total Liabilities ⓘ	8.21	9.02	9.60	8.98	8.12	7.59	6.86	6.27	5.65	5.30
Fixed Assets
Net Fixed Assets ⓘ +	2.23	4.28	6	5.69	5.65	5.35	5.03	4.73	4.44	4.13
Gross Block	2.56	4.74	6.69	6.69	6.97	6.99	7	7.03	7.04	7.04
Accumulated Depreciation	0.33	0.46	0.69	1	1.32	1.65	1.97	2.29	2.60	2.91
CWIP ⓘ	3.77	2.75	1.64	1.41	0.65	0.63	0.63	0.63	0.63	0.63
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.02	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Trade Receivables	0.15	0.16	0.39	0.20	0.16	0.21	0.33	0.43	0.38	0.32
Cash Equivalents	0.04	0.04	0.03	0.03	0.02	0.02	0.04	0.04	0.06	0.02
Others Assets ⓘ	1.99	1.78	1.52	1.65	1.63	1.38	0.82	0.43	0.13	0.19
Total Assets ⓘ	8.21	9.02	9.60	8.98	8.12	7.59	6.86	6.27	5.65	5.30

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Cash Flow From Operating Activity ⓘ +	0.77	0.05	-0.35	-0.23	-0.41	0.01	0.03	0.02	0.04	-0.05
PBT ⓘ	0.42	-0.02	-0.09	-0.67	-0.78	-0.50	-0.72	-0.62	-0.62	-0.40
Adjustment ⓘ	0.66	0.70	0.64	0.80	0.85	0.85	0.88	0.71	0.61	0.31
Changes in Working Capital ⓘ	-0.28	-0.58	-0.89	-0.36	-0.48	-0.35	-0.13	-0.06	0.05	0.04
Tax Paid ⓘ	-0	-0.01	-0	-0	0	0	-0	-0	-0	-0
Cash Flow From Investing Activity ⓘ +	-1.04	-0.35	-0.37	0.23	0.48	-0.01	-0.01	-0.02	-0.02	0
Capex	-1.04	-0.37	-0.37	0	0.48	-0.01	-0.01	-0.02	-0.02	0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0.02	0	0.23	0	0	0	0	0	0
Cash Flow From Financing Activity ⓘ +	0.30	0.29	0.71	0	-0.09	0	0	0	0	0
Net Proceeds from Shares ⓘ	0.20	0.19	0.72	0	0.02	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0.02	-0.06	-0.04	0	-0.11	0	0	0	0	0
Interest Paid ⓘ	0.01	0	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.07	0.16	0.02	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0.03	-0	-0.01	0	-0.01	0	0.02	0	0.02	-0.05

Finance Ratio

PARTICULARS	Mar'00	Mar'01	Mar'02	Mar'03	Mar'04	Mar'05	Mar'06	Mar'07	Mar'08	Mar'09
Ratios
ROE (%)	13.87	-0.57	-2.45	-19.85	-29.87	-23.4	-37.03	-35.93	-42.66	-36.56
ROCE (%)	9.32	3.23	-0.97	-8.77	-11.44	-7.93	-11.75	-10.58	-11.09	-7.63
Asset Turnover Ratio	0.23	0.19	0.17	0.11	0.1	0.14	0.14	0.15	0.15	0.13
PAT to CFO Conversion(x)	1.83	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	23	36	63	101	77	61	99	144	164	183
Inventory Days	6	4	2	3	4	3	2	2	2	3
Payable Days	88	85	70	96	137	119	84	85	91	151

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Classic Biotech & Exports Ltd FAQs

The current trading price of Classic Biotech on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Classic Biotech stood at ₹3.11 Cr

The latest P/E ratio of Classic Biotech as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Classic Biotech as of 31-Dec-1969 is 1.89.

The 52-week high of Classic Biotech is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Classic Biotech is ₹0.70 ( Cr.) .

About Classic Biotech & Exports Ltd

Classic Biotech & Exports, incorporated as a public limited company on June 8, 1994, has business activities in floriculture and tissue culture. The company grows cut flowers at Karimsonnen Hally near Bangalore with an installed capacity of 5.2 million roses and other cut flowers. It obtained technical assistance and marketing support from Oriental Floratech India, a pioneer in the Indian floriculture industry. The company exports cut flowers to the Middle East countries, Gulf countries and the Netherlands auctions.

Milestones:

1994 - Classic Biotech & Exports Ltd was incorporated as a public limited company on June 8. The company received the Certificate of Commencement of Business on June 23, 1994. The company is having its registered office at 133/B, Vengalarao Nagar, Hyderabad.

The company is in the process of setting up a floriculture project at Karimsonnen Hally near Bangalore.

1996 - The company entered into a marketing tie-up with Oriental Floratech India Limited (OFIL) for marketing cut flowers in Holland auctions and for direct markets in the Middle East and Gulf countries.

1997 - During the year under review the company completed three green houses including plantations.

1998 - Directors N Rama Sita, P V Rama Raju and N Jhansi Rani retire.

1999 - The company proposed to enter into Information & Technology with e-commerce based solutions and accordingly a resolution is placed before for the approval for amendment of objects clause.

P Padmavathi and A S S N Raju, directors retire.

2000 - The company, a flower grower from south India, developed an online auction portal christened 'Classicflora.com' to cater to the Indian cut flower trade targeting major flower markets in the Asia-Pacific Rim.

Classic Biotech and Exports (CBEL), engaged in floriculture activity, entered into a memorandum of understanding with Sanjisoft 2000 of Colorado Springs, US.

The company will establish two development centres, one each in Bangalore and Hyderabad. For domestic market capitalisation, it has tied up with the Bangalore-based Brainsoft.

The company is offering a full-fledged international flower auction portal - www.classicflora.com.

The company has a unique concept in diversifying into biotechnology particularly agricultural biotechnology and the company as already ventured and invested heavily in its IT division.

The board of directors decided to retain the company's original name Classic Biotech & Exports.

You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Classic Biotech & Exports Ltd (531670) Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating